Discover trends, market shifts, and competitive outlooks for the joint pain injections industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Joint Pain Injections Market Size from 2025 to 2034?

The market for joint pain injection therapies has seen a robust expansion in recent years. The market is projected to balloon from $5.6 billion in 2024 to $6.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the historical period include a rising elderly population, the widespread occurrence of arthritis, global healthcare campaigns, the digitalization of healthcare systems, and a growing recognition of the importance of managing chronic pain.

We anticipate a swift expansion in the joint pain injections market in the upcoming years, with its worth predicted to escalate to $9.81 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. This projected growth during the forecast period is likely due to the broadening of telehealth services, tailored pain management strategies, initiatives aimed at educating and empowering patients, sustainable healthcare tactics, and nutritional support. Key trends that are expected to emerge in the forecast period encompass restorative medicine, bespoke pain management, inventive injection materials, technologies for rehabilitation and artificial intelligence that enhances injections.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

Which Primay Drivers Are Accelerating Growth in the Joint Pain Injections Market?

Growth in the joint pain injections market is driven by an increasing incidence of arthritis and musculoskeletal diseases. With musculoskeletal ailments acting as the leading cause of disability in 160 nations worldwide, injecting for alleviation of pain and inflammation is becoming more common. Data from June 2023 by Australia’s government agency, the Australian Institute of Health and Welfare, reveals that rheumatoid arthritis accounted for 2.0% of total disease burden and 16% of the muscular skeletal disease related burden. In 2022, there were 1,322 reported deaths, or 5.1 deaths per 100,000 people, equating to 0.7% of total deaths. Consequently, the increasing occurrence of arthritis and musculoskeletal disorder is fuelling the demand in the joint pain injections market.

Which Primary Segments of the Joint Pain Injections Market Are Driving Growth and Industry Transformations?

The joint pain injections market covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections

2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types

3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections

2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections, Allogeneic PRP Injections

4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections, Placental Derived Cell Injections

5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections, Stem Cell Injections, Genetically Engineered Cell Injections

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6482&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Joint Pain Injections Market?# Market?

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Joint Pain Injections Industry Dynamics?

Companies leading the way in the joint pain injections industry are prioritizing the creation of inventive solutions such as single-injection formulations, to enhance patient convenience. In this context, a single-injection formulation is a drug administration method engineered to deliver an exact dosage of a drug in just one injection, maintaining healing impacts over an extended period without the requirement for numerous doses. For instance, in July 2024, LG Chem Ltd., a chemical firm from South Korea, introduced Synovian in China. This novel knee osteoarthritis treatment employs a user-friendly single-injection formulation, marking it as the country’s pioneer in this field. The product is projected to penetrate a substantial market valued close to KRW 200 billion (roughly USD 150 million). The treatment, which was created using proprietary technology, represents innovation in meeting patient requirements. Its primary goal is to offer efficient pain relief with the least administrative inconvenience.

View the full report here:

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

What Parameters Are Used to Define the Joint Pain Injections Market?

Joint pain injections reduce inflammation and discomfort and are typically injected directly into the joint for pain relief. Joint pain is very frequent among the elderly or as a result of pre-existing medical problems or disorders. It can happen as a result of musculoskeletal illnesses such as arthritis, which causes pain and inflammation. The joint pain injections are used to relieve joint pain and inflammation quickly through non-surgical treatments.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6482

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model